140 related articles for article (PubMed ID: 16078660)
1. [Progress in the studies of vasoactive intestinal polypeptide].
Shen ZJ
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):483-5. PubMed ID: 16078660
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat.
Shen ZJ; Wang H; Lu YL; Zhou XL; Chen SW; Chen ZD
BJU Int; 2005 Apr; 95(6):890-4. PubMed ID: 15794804
[TBL] [Abstract][Full Text] [Related]
3. [Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences].
Adaikan PG; Lau LC; Vasatha KS; Susheela K; Ratnam SS
J Urol (Paris); 1990; 96(1):15-8. PubMed ID: 1968931
[TBL] [Abstract][Full Text] [Related]
4. Involvement of vasoactive intestinal peptide (VIP) as a humoral mediator of penile erectile function in the dog.
Aoki H; Matsuzaka J; Yeh KH; Sato F; Fujioka T; Kubo T; Ohhori T; Yasuda N
J Androl; 1994; 15(2):174-82. PubMed ID: 8056641
[TBL] [Abstract][Full Text] [Related]
5. Participation of vasoactive intestinal polypeptide (VIP) as a humoral mediator in the erectile response of canine corpus cavernosum penis.
Yeh KH; Aoki H; Matsuzaka J; Ra S; Sato F; Fujioka T; Ohhori T; Kubo T; Yasuda N
J Androl; 1994; 15(3):187-93. PubMed ID: 7928658
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection.
Cormio L; Gesualdo L; Maiorano E; Bettocchi C; Palumbo F; Traficante A; Schena FP; Selvaggi FP
Int J Impot Res; 2005; 17(1):23-6. PubMed ID: 15526009
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of the K(ATP) channel restores age-related erectile dysfunction in rats.
So I; Chae MR; Lee SW
BJU Int; 2007 Nov; 100(5):1154-60. PubMed ID: 17645416
[TBL] [Abstract][Full Text] [Related]
8. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study.
Juenemann KP; Lue TF; Luo JA; Jadallah SA; Nunes LL; Tanagho EA
J Urol; 1987 Oct; 138(4):871-7. PubMed ID: 2888903
[TBL] [Abstract][Full Text] [Related]
9. A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.
Gozes I; Fridkin M
J Clin Invest; 1992 Sep; 90(3):810-4. PubMed ID: 1522236
[TBL] [Abstract][Full Text] [Related]
10. [Intrapenile neurotransmission. Physiologic data and practical consequences].
Buvat J
Ann Urol (Paris); 1989; 23(5):359-66. PubMed ID: 2560359
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection.
Willis E; Ottesen B; Wagner G; Sundler F; Fahrenkrug J
Acta Physiol Scand; 1981 Dec; 113(4):545-7. PubMed ID: 7348038
[No Abstract] [Full Text] [Related]
12. Potential application of gene therapy for the treatment of erectile dysfunction.
Bivalacqua TJ; Hellstrom WJ
J Androl; 2001; 22(2):183-90. PubMed ID: 11229791
[No Abstract] [Full Text] [Related]
13. Intracavernous administration of SIN-1+VIP in an in vivo rabbit model for erectile function.
Sazova O; Kadioğlu A; Gürkan L; Kayaarasi Z; Bross S; Manning M; Jünemann KP
Int J Impot Res; 2002 Feb; 14(1):44-9. PubMed ID: 11896477
[TBL] [Abstract][Full Text] [Related]
14. [Vasoactive intestinal polypeptide (VIP)].
Iwanaga T
Nihon Rinsho; 2002 Jun; 60 Suppl 6():35-8. PubMed ID: 12166175
[No Abstract] [Full Text] [Related]
15. Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate.
Shah PJ; Dinsmore W; Oakes RA; Hackett G
Curr Med Res Opin; 2007 Oct; 23(10):2577-83. PubMed ID: 17875241
[TBL] [Abstract][Full Text] [Related]
16. Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment.
Gozes I; Reshef A; Salah D; Rubinraut S; Fridkin M
Endocrinology; 1994 May; 134(5):2121-5. PubMed ID: 8156912
[TBL] [Abstract][Full Text] [Related]
17. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.
Ottesen B; Wagner G; Virag R; Fahrenkrug J
Br Med J (Clin Res Ed); 1984 Jan; 288(6410):9-11. PubMed ID: 6140066
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide release during penile erection in man.
Virag R; Ottesen B; Levy C; Wagner G
Lancet; 1982 Nov; 2(8308):1166. PubMed ID: 6128487
[No Abstract] [Full Text] [Related]
19. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal polypeptide in relation to penile erection in the cat evoked by pelvic and hypogastric nerve stimulation.
Andersson PO; Björnberg J; Bloom SR; Mellander S
J Urol; 1987 Aug; 138(2):419-22. PubMed ID: 2885430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
